Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.3.1403

Reversal of Resistance towards Cisplatin by Curcumin in Cervical Cancer Cells  

Roy, Madhumita (Department of Environmental Carcinogenesis and Toxicology)
Mukherjee, Sutapa (Chittaranjan National Cancer Institute)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.3, 2014 , pp. 1403-1410 More about this Journal
Abstract
Epigenetic regulators like histone deacetylases (1 and 2), and viral onco-proteins (E6/E7) are known to be overexpressed in cervical cancer cells. The present study was designed to investigate the effect of curcumin on HDACs (1 and 2) and HPV E6/E7 in the cervical cancer cell line SiHa and a drug resistant clone $SiHa^R$ (derived from SiHa). It was further intended to investigate whether curcumin could sensitize the cells towards cisplatin induced cell killing by modulation of multi drug resistant proteins like MRP1 and Pgp1. Curcumin inhibited HDACs, HPV expression and differentially increased acetylation and up-regulation of p53 in SiHa and $SiHa^R$, leading to cell cycle arrest at G1-S phase. Up-regulation of pRb, p21, p27 and corresponding inhibition of cyclin D1 and CDK4 were observed. Cisplatin resistance in $SiHa^R$ due to over-expression of MRP1 and Pgp1 was overcome by curcumin. Curcumin also sensitized both the cervical cancer cells towards cisplatin induced cell killing. Inhibition of HDACs and HPVs led to cell cycle arrest at G1/S phase by alteration of cell cycle regulatory proteins. Suppression of MRP1 and Pgp1 by curcumin resulted in sensitization of cervical cancer cells, lowering the chemotherapeutic dose of the drug cisplatin.
Keywords
HDACs; E6/E7; MDR; cisplatin; cervical cancer;
Citations & Related Records
Times Cited By KSCI : 10  (Citation Analysis)
연도 인용수 순위
1 Tyagi AK, Agarwal C, Chan DC, et al (2004). Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Reports, 11, 493-9.
2 Szakacs G, Paterson JK, Ludwig JA, et al (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov, 5, 219-34.   DOI   ScienceOn
3 Takai N, Kira N, Ishii T, et al (2011). Novel chemotherapy using histone deacetylase inhibitors in cervical cancer. Asian Pac J Cancer Prev, 12, 575-80.
4 Tanaki T, Fukasawa K, Suzuki-Takahashi I, et al (2004). Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro. Biochem Biophys Res Commun, 316, 252-5.   DOI   ScienceOn
5 Vinod BS, Maliekal TT, Anto RJ (2013). Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance. Antioxidants and Redox Signaling, 18, 1307-48.   DOI   ScienceOn
6 Wesierska-Gadek J, Krystof V (2009). Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia? Ann NY Acad Sci, 1171, 228-41.   DOI   ScienceOn
7 Yin HT, Zhang DG, Wu XL, et al (2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12.   과학기술학회마을   DOI   ScienceOn
8 Zhang E-Y, Tang X-D (2012). Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer. Asian Pac J Cancer Prev, 13, 5363-9.   과학기술학회마을   DOI   ScienceOn
9 Zhou X, Gu Y, Zhang S-L (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: A huge review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14.   과학기술학회마을   DOI   ScienceOn
10 Sahin K, Tuzcu M, Basak N, et al (2012). Sensitization of cervical cancer cells to cisplatin by genistein: The role of $NF{\kappa}B$ and Akt/mTOR signaling pathways. J Oncol, 2012, 1-6.
11 Narisawa-Saito M, Kiyono T (2007). Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci, 98, 1505-11.   DOI   ScienceOn
12 Raybould R, Fiander A, Hibbitts S (2011). Human papillomavirus integration and its role in cervical malignant progression. The Open Clinical Cancer J, 5, 1-17.   DOI
13 Roy M, Mukherjee S, Sarkar R, Biswas J (2011). Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, $NF{\kappa}B$ and HDAC in breast cancer. Ther Delivery, 2, 1275-93.   DOI
14 Sarkar FH, Li Y (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res, 66, 3347-50.   DOI   ScienceOn
15 Subramanian N, Chinnappan S (2013). Prediction of promiscuous epitopes in the E6 protein of three high risk human papilloma viruses: a computational approach. Asian Pac J Cancer Prev, 14, 4167-75.   과학기술학회마을   DOI   ScienceOn
16 Singh M, Singh N (2011). Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Mol Cell Biochem, 347, 1-11.   DOI
17 Singh M, Singh U, Mathur N, et al (2012). Expression of p-glycoprotein is positively correlated with p53 in human papilloma virus induced squamous intraepithelial lesions of uterine cervix: poor prognosis association. Asian Pac J Cancer Prev, 13, 6039-45.   과학기술학회마을   DOI   ScienceOn
18 Song W, Jiang R, Zhao C-M (2012). Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cell. Asian Pac J Cancer Prev, 13, 5619-25.   DOI   ScienceOn
19 Mahjoubi F, Akbari S (2013). Multidrug resistance-associated protein 1 predicts relapse in Iranian childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev, 13, 2285-9.   과학기술학회마을   DOI   ScienceOn
20 Longworth MS, Laimins LA (2004). The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papilloma virus type 31. J Virol, 78, 3533-41.   DOI
21 Luczak MW, Jagodzinski PP (2008). Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells. Cancer Lett, 272, 53-60.   DOI   ScienceOn
22 Mockel J, Quaas J, Meisel H, Endres AS, Schneider V (2011). Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia. Anal Quant Cytol Histol, 33, 311-5.
23 Maher DM, Bell MC, O'Donnell EA, et al (2011). Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo(a)pyrene-induced upregulation of HPV-E7. Mol Carcinog, 50, 47-57.   DOI   ScienceOn
24 Malumbres M, Barbacid M (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer, 9, 153-66.   DOI   ScienceOn
25 Mizuguchi Y, Specht S, Lunz JG III, et al (2012). SPRR2a enhances p53 deacetylation through HDAC1 and downregulates p21 promoter activity. BMC Mol Cancer, 13, 20-9.
26 Mukherjee S, Sarkar R, Biswas J, Roy M (2012) Curcumin inhibits histone deacetylase leading to cell cycle arrest and apoptosis via up-regulation of p21 in breast cancer cells. Int J Green Nanotech, 4, 183-97.   DOI
27 Munger K, Basile JR, Duensing S, et al (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-98.   DOI
28 Dong X, Mumper RJ (2010). Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine, 5, 597-615.   DOI   ScienceOn
29 Chekhun VF, Lukyanova NY, Kovalchuk O, et al (2007). Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther, 6, 1089-98.   DOI   ScienceOn
30 Choi BH, Kim CG, Lim Y, et al (2008). Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/$NF{\kappa}B$ pathway. Cancer Lett, 259, 111-18.   DOI   ScienceOn
31 Jayshree RS, Sreenivas A, Tessy M et al (2009). Cell intrinsic and extrinsic factors in cervical carcinogenesis. Indian J Med Res, 130, 286-95.
32 Dai X-Z, Yin H-T, Sun L-F, et al (2013). Potential therapeutic efficacy of curcumin in liver cancer. Asian Pac J Cancer Prev, 14, 3855-59.   과학기술학회마을   DOI   ScienceOn
33 Ermakova SP, Kang BS, Choi BY, et al (2006). (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res, 66, 9260-69.   DOI   ScienceOn
34 Huang BH, Laban M, Leung CH, et al (2005). Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase1. Cell Death Differ, 12, 395-404.   DOI   ScienceOn
35 Kim H, Kim SN, Park YS, et al (2011). HDAC inhibitors downregulate MRP2 expression in multidrug resistant cancer cells: implication for chemosensitization. Int J Oncol, 38, 807-12.
36 Kuo MT (2009). Redox regulation of multidrug resistance in cancer chemotherapy: Molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal, 11, 99-133.   DOI   ScienceOn
37 Lin Z, Bazzaro M, Wang M-C, et al (2009). Combination of proteasome and HDAC inhibitors for therapy of uterine cervical cancer. Clin Cancer Res, 15, 570-77.   DOI   ScienceOn
38 Basu P, Dutta S, Begum R, et al (2013). Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: A phase II randomized controlled study. Asian Pac J Cancer Prev, 14, 5753-59.   과학기술학회마을   DOI   ScienceOn
39 Brehm A, Nielsen SJ, Miska EA, et al (1999). The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. Embo J, 18, 2449-58.   DOI   ScienceOn
40 Biswas J, Roy S, Mukherjee S, et al (2010). Indian spice curcumin may be an effective strategy to combat the genotoxicity of arsenic in swiss albino mice. Asian Pac J Cancer Prev, 11, 239-46.
41 Cheah PL, Looi LM, Teoh KH, et al (2012). p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies. Asian Pac J Cancer Prev, 13, 469-72.   과학기술학회마을   DOI   ScienceOn
42 Witt O, Deubzer HE, Milde T, et al (2009). HDAC family: What are the cancer relevant targets? Cancer Lett, 277, 8-21.   DOI   ScienceOn